Kellerhals Carrard advised Positrigo throughout its latest financing round. Raising an amount of CHF 7 million, the round in question was led by HealthCap, with participation from Navivo Capital as well as several family offices
Tags :Kellerhals Carrard
Kellerhals Carrard advised Swiss chocolate manufacturer Maestrani Schweizer Schokoladen on its acquisition of Delafaille, a family business specialising in the production of Belgian truffles and pralines. The acquisition also includes the selling part’s Czech
Kellerhals Carrard advised the Bern-based sports medicine start-up Pershing Medical in its acquisition of the Ligamys™ product line—a technology for the natural healing of the anterior cruciate ligament (ACL)—from the international medical technology
Kellerhals Carrard advised Swiss deep tech company Jua.ai AG on its USD 11M Series A financing Round. The context Headquartered in Zurich, Jua.ai AG specialises on AI-based Earth simulation aimed at transforming
Kellerhals Carrard advised DRS Investment on the acquisition of a controlling interest in the newly formed factory group. The context A merger of Germany’s VIGNOLD Group and Swiss marketing service provider The Factory, the
Kellerhals Carrard advised Maestrani Schweizer Schokoladen on taking over the production infrastructure for chocolate-coated marshmallow treats (Schokoladenküsse) from Chocolat Ammann. The context Pursuant to the acquisition, the Swiss family-owned company further expands its brand
Kellerhals Carrard advises SKAN on its acquisition of Metronik. The SIX-listed Swiss company, specialised in isolator systems for the (bio-) pharmaceutical industry, has signed an agreement acquire a 76% stake in the Slovenian Metronik, a
Kellerhals Carrard advised Groupe Minoteries on its takeover of the traditional Schweizerische Schälmühle E. Zwicky. The context Pursuant to the transaction, the long-term succession of the Klopfenstein family will be preserved and the
Swiss precision medicines company Haya Therapeutics completed a $65 million series A funding round. In connection with the deal, Kellerhals Carrard represented lead investors Sofinnova Partners and Earlybird Venture Capital, while Lenz & Staehelin assisted Eli
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
